| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 471 | 2011 |
| Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community F Megraud, R Bruyndonckx, S Coenen, L Wittkop, TD Huang, M Hoebeke, ... Gut 70 (10), 1815-1822, 2021 | 228 | 2021 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 201 | 2014 |
| Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review S Galmiche, LBL Nguyen, E Tartour, X de Lamballerie, L Wittkop, ... Clinical Microbiology and Infection 28 (2), 163-177, 2022 | 175 | 2022 |
| Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma PH Nguyen, J Giraud, L Chambonnier, P Dubus, L Wittkop, G Belleannée, ... Clinical Cancer Research 23 (6), 1586-1597, 2017 | 166 | 2017 |
| Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 … A Cozzi-Lepri, M Noguera-Julian, F Di Giallonardo, R Schuurman, ... Journal of antimicrobial chemotherapy 70 (3), 930-940, 2015 | 144 | 2015 |
| The incidence of AIDS-defining illnesses at a current CD4 count≥ 200 cells/µL in the post–combination antiretroviral therapy era A Mocroft, HJ Furrer, JM Miro, P Reiss, C Mussini, O Kirk, S Abgrall, ... Clinical infectious diseases 57 (7), 1038-1047, 2013 | 135 | 2013 |
| Effect estimates in randomized trials and observational studies: comparing apples with apples S Lodi, A Phillips, J Lundgren, R Logan, S Sharma, SR Cole, A Babiker, ... American journal of epidemiology 188 (8), 1569-1577, 2019 | 116 | 2019 |
| Non-AIDS defining cancers in the D: A: D Study-time trends and predictors of survival: a cohort study SW Worm, M Bower, P Reiss, F Bonnet, M Law, G Fätkenheuer, ... BMC infectious diseases 13, 1-15, 2013 | 100 | 2013 |
| CD4: CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus–infected patients on antiretroviral therapy: the Antiretroviral Therapy Cohort … A Trickey, MT May, P Schommers, J Tate, SM Ingle, JL Guest, MJ Gill, ... Clinical Infectious Diseases 65 (6), 959-966, 2017 | 99 | 2017 |
| The negative impact of HBV/HCV coinfection on cirrhosis and its consequences S Pol, G Haour, H Fontaine, C Dorival, V Petrov‐Sanchez, M Bourliere, ... Alimentary pharmacology & therapeutics 46 (11-12), 1054-1060, 2017 | 98 | 2017 |
| Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies A Trickey, CA Sabin, G Burkholder, H Crane, AA Monforte, M Egger, ... The Lancet HIV 10 (5), e295-e307, 2023 | 95 | 2023 |
| Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013 Late Presenters Working Group in COHERE in EuroCoord Eurosurveillance 20 (47), 30070, 2015 | 89 | 2015 |
| Global trends in CD4 cell count at the start of antiretroviral therapy: collaborative study of treatment programs Clinical Infectious Diseases 66 (6), 893-903, 2018 | 85 | 2018 |
| Effect of Cytomegalovirus-induced immune response, self antigen–induced immune response, and microbial translocation on chronic immune activation in successfully treated HIV … L Wittkop, J Bitard, E Lazaro, D Neau, F Bonnet, P Mercie, M Dupon, ... The Journal of infectious diseases 207 (4), 622-627, 2013 | 83 | 2013 |
| HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens D da Silva, L Van Wesenbeeck, D Breilh, S Reigadas, G Anies, ... Journal of Antimicrobial Chemotherapy 65 (6), 1262-1269, 2010 | 80 | 2010 |
| All-oral direct-acting antiviral regimens in HIV/hepatitis C virus–coinfected patients with cirrhosis are efficient and safe: real-life results from the prospective ANRS CO13 … P Sogni, C Gilbert, K Lacombe, L Piroth, E Rosenthal, P Miailhes, ... Clinical Infectious Diseases 63 (6), 763-770, 2016 | 71 | 2016 |
| Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients P Duffau, L Wittkop, E Lazaro, F Le Marec, C Cognet, P Blanco, ... Aids 29 (16), 2099-2108, 2015 | 61 | 2015 |
| Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation L Wittkop, A Schwarz, A Cassany, S Grün‐Bernhard, M Delaleau, B Rabe, ... Cellular microbiology 12 (7), 962-975, 2010 | 59 | 2010 |
| Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients–French ANRS CO13 HEPAVIH cohort L Piroth, L Wittkop, K Lacombe, E Rosenthal, C Gilbert, P Miailhes, ... Journal of hepatology 67 (1), 23-31, 2017 | 58 | 2017 |
Fabrice BonnetBordeaux在 chu-bordeaux.fr 的电子邮件经过验证
